Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Int J Dev Neurosci. 2014 Oct 5;0:195–203. doi: 10.1016/j.ijdevneu.2014.09.004

Figure 3.

Figure 3

Mean (± SEM) peak ASR amplitude by treatment across ISIs (0–4000 ms). No significant treatment effect was found on control trials (0 and 4000 ms ISIs), suggesting that Tat1-86 did not affect the animals’ baseline startle. Both groups displayed peak inhibition at the 80 ms ISI. The characteristic quadratic fit of the PPI ISI function for the VEH-treated animals was shifted in the Tat1-86 -treated animals to also include a prominent linear component to the PPI ISI function.